Pharmacists press U.S. Congress to pass pro-pharmacist, pro-patient legislation

More than 300 independent community pharmacists from across the United States gathered this week for the National Community Pharmacists Association (NCPA) 2016 Congressional Pharmacy Summit just outside Washington, DC.

More than 300 independent community pharmacists from across the United States gathered this week for the National Community Pharmacists Association (NCPA) 2016 Congressional Pharmacy Summit just outside Washington, DC. "The vital role independent community pharmacists play in improving patient outcomes and reducing overall spending is being undermined by pressing concerns in the marketplace that negatively affect pharmacists," said NCPA CEO B. Douglas Hoey, RPh, MBA. "In response, these clinically-trained medication experts have flocked to our nation's capital for the NCPA 2016 Congressional Pharmacy Summit this week to engage in vigorous, informative advocacy with members of Congress and their staff." Summit attendees visited member offices in the U.S. House of Representatives and Senate to urge greater transparency for generic prescription drug reimbursements in government-run programs by enacting H.R. 244, the MAC Transparency Act. The pharmacists also lobbied for a requirement that Medicare Part D and PBM corporations report pharmacy price concessions when prescription drugs are dispensed.